Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Interim Management Statement

2 Feb 2010 07:00

RNS Number : 4992G
e2v technologies PLC
02 February 2010
Β 

ο»Ώ

2 February 2010

Β 

e2v technologies plc

Β 

Interim Management Statement

Β 

e2v technologies, the specialist developer and manufacturerΒ of high technology components and sub-systems, is today providing this Interim Management Statement coveringΒ the periodΒ from 1 October 2009 to 1 February 2010.

Β 

Group trading since the half year has continued in line with management's expectations and this reflects general market softness.

Β 

In the Electron Devices and Subsystems division, the science and medical sector for radiotherapy new equipment sales has stabilised with spares revenues steady, while commercial and industrial markets show some signs of recovery. The defence sector has performed below expectations, reflecting lower levels of new order placement which we anticipate will continue into the next financial year.

Β 

Within Imaging, performance reflects the continued lower demand in the dental markets, partially offset by increased activity in space related applications. The commercial and industrial sector is stable but with some signs of recovery.

Β 

Specialist Semiconductors has grown with QP Semiconductors offsetting the decline in the underlying business. Demand in the defence sector remains firm.

Β 

Sensors, the smallest division, has continued to achieve modest growth across its portfolio of businesses.

Β 

Order intake in the quarter was equivalent to sales, resulting in a closing order book for use over the coming 12 months of Β£105m (31 December 2008: Β£108m at constant exchange rates).

Β 

The formal employee consultations in relation to the potential restructuring in France and the UK are in line with our planned timetable. The scale of the programme has led to some level of disruption and this risk remains. The overall restructuring programme continues to be subject to close management attention.

Β 

Net borrowings* at 31 December 2009 decreased from the 30 September 2009 by Β£52.8m to Β£52.4m. This was primarily due to the firm placing and rights issue announced on 29 October 2009, the gross proceeds of which were Β£55.8m.

Β 

*Note: Net borrowings excludes capitalised borrowing costs

Β 

Β 

Β 

Β 

For further information:

Β 

e2v technologies plc

Tel: +44 (0)1245 493493

Keith Attwood/Charles Hindson

www.e2v.com

Financial Dynamics

Tel: +44 (0)20 7831 3113

Jon Simmons/Sophie Kernon

Β 

NOTES FOR EDITORS

Β 

e2v

Β 

e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for medical & science, aerospace & defence, and commercial & industrial markets.

Β 

e2v is organised into four divisions:

Β 

Β·; High performance electron devices and subsystems for applications including defence electronic countermeasures, radiotherapy cancer treatment, radar systems, industrial heating, satellite communications amplifiers and digital television transmitters.

Β·; Advanced CCD and CMOS imaging sensors and cameras for applications including space, science and life science imaging, industrial process control, intra-oral and panoramic dental X-ray systems, military surveillance and automotive imaging.

Β·; Specialist SemiconductorsΒ -Β including logic, memory and microprocessors forΒ high reliability microprocessor and MRAM requirements, in partnership with Freescale SemiconductorΒ andΒ Everspin,Β mission-critical avionics and defence programs requiring high reliability integrated circuits, high speed data convertersΒ and sensor data acquisitionΒ utilising mixed signal application specific devices.

Β·; A range of professional sensing products for applications including environmental safety, x-ray spectroscopy, automotive alarm and security systems, microwave radar and safety and arming devices, fire rescue and security thermal imaging.

Β 

For the year ended 31 March 2009, e2v achieved sales of Β£233m and is listed on the London Stock Exchange. In October 2008 e2v acquired QP semiconductor, a leading US-based designer and supplier of specialty semiconductor components used in military and aerospace applications, establishing e2v's first US manufacturing base.

Β 

The Company is headquartered in the United Kingdom and has approximately 1500 employees in six production facilities across Europe and North America. e2v also operates a global network of sales and technical support offices, supported by local distributors and resellers.

Β 

Further information is available from www.e2v.com

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSUGUQPPUPUGBG
Date   Source Headline
22nd Sep 20112:09 pmRNSHolding(s) in Company
12th Sep 20115:02 pmRNSTotal Voting Rights
8th Aug 20113:52 pmRNSHolding(s) in Company
4th Aug 20117:00 amRNSVermiculite Processing System Field Trial
28th Jul 20117:00 amRNSNew Banking Facilities
27th Jul 20114:28 pmRNSResult of AGM
15th Jul 201110:17 amRNSHolding(s) in Company
8th Jul 201110:47 amRNSStatement Re Boiler Room Scams
8th Jun 20113:46 pmRNSTotal Voting Rights
6th Jun 20114:49 pmRNSFinal Dividend Timetable
6th Jun 20117:00 amRNSFinal Results
27th May 20119:45 amRNSHolding(s) in Company
21st Apr 20111:55 pmRNSTotal Voting Rights
21st Apr 201112:56 pmRNSDirector/PDMR Shareholding
12th Apr 20113:00 pmRNSe2v awarded up to £6.2m development grant
11th Apr 20117:00 amRNSYear end trading update & dividend declaration
4th Mar 201110:30 amRNSHolding(s) in Company
22nd Feb 20113:45 pmRNSHolding(s) in Company
2nd Feb 20112:00 pmRNSDirector/PDMR Shareholding
31st Jan 20117:00 amRNSInterim Management Statement
28th Jan 20111:30 pmRNSDirectorate Change
20th Jan 20112:30 pmRNSBank arrangements concerning dividends
6th Dec 20104:57 pmRNSTotal Voting Rights
19th Nov 20103:21 pmRNSHolding(s) in Company
18th Nov 201012:12 pmRNSChange of Director's Details
17th Nov 20104:40 pmRNSHolding(s) in Company
15th Nov 20107:00 amRNSHalf Yearly Report
9th Nov 201012:11 pmRNSHolding(s) in Company
28th Oct 20107:00 amRNSAppointment of New Non Executive Director
12th Oct 201012:15 pmRNSHolding(s) in Company
11th Oct 20107:00 amRNSPeriod end update
7th Sep 20107:00 amRNSUpdate on Restructuring
25th Aug 201010:40 amRNSHolding(s) in Company
11th Aug 201011:15 amRNSHolding(s) in Company
4th Aug 20108:45 amRNSAwards under Long Term Incentive Plan
29th Jul 20102:57 pmRNSAGM Statement
26th Jul 20107:00 amRNSStrategy Briefing
23rd Jul 201012:42 pmRNSTotal Voting Rights
19th Jul 20107:00 amRNSInterim Management Statement
14th Jul 201010:15 amRNSHolding(s) in Company
21st Jun 20104:35 pmRNSPrice Monitoring Extension
4th Jun 201011:38 amRNSHolding(s) in Company
17th May 201012:53 pmRNSTotal Voting Rights
10th May 20107:00 amRNSAppointment of corporate broker
7th May 20102:00 pmRNSHolding(s) in Company
4th May 20101:35 pmRNSHolding(s) in Company
29th Apr 20109:19 amRNSAdditional Listing
28th Apr 20103:40 pmRNSHolding(s) in Company
12th Apr 20107:00 amRNS2010 Year End Trading update
7th Apr 20109:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.